On ECHEMI

Hangzhou Meiya Pharmacy Co.,Ltd.

Hangzhou,Zhejiang,China
Favorite Supplier
 1572 people visit

Company Profile

Hangzhou Meiya Pharmaceutical co., ltd is a high high-tech company mainly produces various biochemical products. We have a high lever research group to guarantee the technique. Our main products include nucleic acids, nucleotides and enzymes. As the advanced produce process, the strict quantity control, and the high products quality, the products passed GMP certificate and are well sold in China and many of other countries.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

2-Fluoroadenosine

Adenosine,2-fluoro-;2-Fluoroadenosine;2-Fluoro-9-β-D-ribofuranosyladenine;NSC 30605
146-78-1 - / 98% Inquiry

5'-Cytidylic acid, homopolymer

5′-Cytidylic acid,homopolymer;5′-Cytidylic acid,polymers;Poly(5′-cytidylic acid);Poly(C);Poly(cytidylic acid);Poly(CMP);NSC 120953;Polycytidylic acid;25249-24-5;55679-94-2;162756-88-9
30811-80-4 - / 98% Inquiry

Adenosine 5'-(trihydrogen diphosphate)

Adenosine 5′-(trihydrogen diphosphate);Adenosine 5′-(trihydrogen pyrophosphate);Adenosine diphosphate;Adenosine 5′-pyrophosphate;Adenosine 5′-pyrophosphoric acid;ADP;Adenosine 5′-diphosphate;5′-ADP;Adenosine pyrophosphate;Adenosine 5′-diphosphoric acid;Adenosine,5′-(trihydrogen diphosphate);ADP (nucleotide);α-ADP;84412-16-8;896506-82-4;905904-58-7
58-64-0 - / 98% Inquiry

Adenosine 5'-(trihydrogen diphosphate) barium sa

ADP.Ba;ADPBARIUMSALT;ADENOSINE5'-DIPHOSPHATE,BARIUMSALT;ADENOSINE5'-PYROPHOSPHATE,BARIUMSALT;Adenosine5'-(trihydrogendiphosphate)bariumsalt;Adenosine5'-(trihydrogendiphosphate)bariumsalt(1:3)
40436-88-2 - / 98% Inquiry

Adenosine 5'-(trihydrogen diphosphate) monopotas

72696-48-1 - / 98% Inquiry

Adenosine 5'-monophosphate

5′-Adenylic acid;5′-AMP;Adenosine 5′-monophosphate;Adenosine-5-monophosphoric acid;Adenosine phosphate;Adenosine 5′-phosphate;Adenosine 5′-phosphoric acid;Lycedan;My-B-Den;Phosaden;Phosphentaside;AMP;Adenosine-5′-monophosphoric acid;Adenylic acid;AMP (nucleotide);Adenovite;Cardiomone;Phosphaden;Adenosine 5′-(dihydrogen phosphate);Adenosine monophosphate;NSC 20264;β-D-Adenosine 5′-phosphate;47286-65-7;47287-97-8;53624-78-5;67583-85-1;697214-87-2;162756-82-3
61-19-8 - / 98% Inquiry

Adenosine 5'-monophosphate monohydrate

5'-AMP H2O;5'-AMP MONOHYDRATE;ADENOSINE 5'-MONOPHOSPHATE MONOHYDRATE;ADENOSINE 5'-MONOPHOSPHORIC ACID MONOHYDRATE;ADENYLIC ACID MONOHYDRATE;A-5'-P;ADENOSINE 5'-MONOPHOSPHATE FREE ACID97+%FROM YEAS;5'-AMP=Adenylicacid
18422-05-4 - / 95.0% Inquiry

Adenosine triphosphate

Adenosine 5′-(tetrahydrogen triphosphate);Adenosine 5′-triphosphate;Adenosine triphosphate;Adenosine 5′-triphosphoric acid;Atipi;ATP (nucleotide);5′-ATP;Atriphos;Striadyne;Triphosphoric acid adenosine ester;Adenylpyrophosphoric acid;Adetol;Triadenyl;Adephos;Triphosphaden;Adynol;Glucobasin;ATP;Cardenosine;Adenosine,5′-(tetrahydrogen triphosphate);Fosfobion;Myotriphos;Phosphobion;5: PN: WO2010069064 FIGURE: 3A claimed sequence;Adenosine-5′-triphosphate;10168-83-9;16488-07-6;51569-41-6;71800-44-7;84412-18-0;896506-78-8;917074-14-7;1259312-93-0
56-65-5 - / 98% Inquiry

Adenosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[[4-(1,1-dimethylethyl)phenoxy]acetyl]-,3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

DMT-2'O-TBDMS-RA(TAC) AMIDITE 0.5GAB;DMT-2'O-TBDMS-RA(TAC) AMIDITE 0.5G89;DMT-2'O-TBDMS-rA(tac) Amidite 5g, Singl.;DMT-2'O-TBDMS-rA(tac) Amidite 10g, Singl;DMT-2'O-TBDMS-rA(tac) Amidite 10g,6Pack;DMT-2'O-TBDMS-rC(tac) Amidite;DMT-2'O-TBDMS-rA(tac) Amidite 2,5g, 12Pa;DMT-2'O-TBDMS-rA(tac) Amidite 4g, 12Pack
149989-64-0 - / 98% Inquiry

Adenosine,N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-,3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

Bz-rA Phosphoramidite;DMT-2"O-TBDMS-Ra(Bz) Phosphoramidite;(2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite;DMT-2"O-TBDMS-rA(bz) amidite;N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]purin-6-yl]benzamide;DMT-2"O-TBDMS-rA(bz) Pharmadite(R);DMT-2"O-TBDMS-rA(bz) Phosphoramidite, configured for ABI;DMT-2"O-TBDMS-rA(bz) Phosphoramidite, configured for MerMade;N-Benzoyl-5"-O-(4,4-Dimethoxytrityl)-2"-O-[(tert-butyl)dimethylsilyl]adenosine-3"-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite;C53H66N7O8PSi
104992-55-4 - / 98% Inquiry

Adenosine-5'-diphosphate trilithium salt

Adenosine 5′-(trihydrogen diphosphate),trilithium salt;Adenosine 5′-(trihydrogen pyrophosphate),trilithium salt
31008-64-7 - / 98% Inquiry

Bucladesine

Adenosine,N-(1-oxobutyl)-,cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate;Butyramide,N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-,cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate;Butyramide,N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-,2′-butyrate,cyclic 3′,5′-phosphate;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.;Cyclic AMP N6,2′-O-dibutyrate;N6,2′-O-Dibutyryladenosine cyclic 3′,5′-monophosphate;N6,2′-O-Dibutyryl cyclic 3′,5′-adenosine monophosphate;Dibutyryl cyclic adenosine monophosphate;Dibutyryl cyclic 3′,5′-AMP;Dibutyryl 3′,5′-cyclic adenosine monophosphate;N6,2′-Dibutyryladenosine cyclic 3′,5′-(hydrogen phosphate);Dibutyryl 3′,5′-cyclic AMP;Dibutyryl cyclic AMP;N6,O2′-Dibutyrylcyclic adenosine 3′,5′-phosphate;Dibutyryl cyclic 3′,5′-adenylic acid;Dibutyryl-3′,5′-adenosine monophosphate;N6,2′-O-Dibutyryl 3′,5′-cyclic adenosine monophosphate;N6,2′-O-Dibutyryladenosine 3′,5′-monophosphate;Dibutyryladenosine 3′,5′-monophosphate;Dibutyryl cyclic adenosine 3′,5′-monophosphate;N6,O2′-Dibutyryl cyclic AMP;N6,O2′-Dibutyryl adenosine-3′,5′-phosphate;N6,O2′-Dibutyryl cyclic 3′,5′-AMP;N6,O2′-Dibutyryl 3′,5′-AMP;Dibutyryladenosine cyclic 3′,5′-monophosphate;Dibutyryladenosine 3′,5′-cyclic phosphate;Dibutyryladenosine cyclic monophosphate;Dibutyryladenosine 3′,5′-cyclic monophosphate;Dibutyryl-3′,5′-AMP;N6,2′-O-Dibutyryl cyclic AMP;N6-2′-O-Dibutyryl-3′,5′-AMP;130715-01-4;633313-87-8;251294-71-0
362-74-3 - / 98% Inquiry

Cyclic AMP

Adenosine,cyclic 3′,5′-(hydrogen phosphate);Adenosine 3′,5′-cyclic phosphate;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.;3′,5′-AMP;Adenosine cyclic 3′,5′-monophosphate;Adenosine 3′,5′-cyclophosphate;Adenosine 3′,5′-monophosphate;Adenosine 3′,5′-phosphate;Cyclic adenosine 3′,5′-phosphate;Cyclic 3′,5′-adenylic acid;Cyclic 3′,5′-monophosphate adenosine;Cyclic-3′,5′-phosphate adenosine;Cyclic AMP;Cyclic adenosine 3′,5′-monophosphate;Cyclic 3′,5′-AMP;cAMP;Adenosine cyclic monophosphate;NSC 143670;NSC 94017;AMPc;NQZ-026;11002-78-1
60-92-4 - / 98% Inquiry

Monopotassium phosphite

Phosphonic acid,potassium salt (1:1);Phosphonic acid,monopotassium salt;Potassium phosphite (KH2PO4);Monopotassium phosphonate;Monopotassium phosphite;Potassium dihydrogen phosphite;Foli-R-Fos;Potassium phosphite (KH2PO3);15478-79-2
13977-65-6 - / 95% Inquiry

Polyinosinic acid

5′-Inosinic acid,homopolymer;5′-Inosinic acid,polymers;Poly(5′-inosinic acid);Polyinosinic acid;Poly(rI);Poly(IMP);NSC 120952;25249-22-3
30918-54-8 - / 50% Inquiry

Polyinosinic acid-polycytidylic acid

5′-Inosinic acid,homopolymer,complex with 5′-cytidylic acid homopolymer (1:1);5′-Inosinic acid,polymers,complex with 5′-cytidylic acid polymers (1:1);5′-Cytidylic acid,polymers,complex with 5′-inosinic acid polymers (1:1);5′-Cytidylic acid,homopolymer,complex with 5′-inosinic acid homopolymer (1:1);Poly(C).poly(I);Polyribocytidylic acid-polyriboinosinic acid complex;Poly(C:I);Polycytidylic-polyinosinic acid;Polyinosinic-polycytidylic acid complex;Polyinosinic-polycytidylic acid;Poly(rI:rC);Polyinosinic acid:polycytidylic acid;Polyinosinate:polycytidylate;Polyinosinic acid:polycytidylic acid complex;Poly(I).poly(C);Poly(rI).poly(rC);Poly(I:C);Poly(rI):poly(rC);Poly(cytidylic acid)-poly(inosinic acid);Poly(I).poly(C) complex;Poly(rI)-poly(rC);5′-Inosinic acid homopolymer-5′-cytidylic acid homopolymer complex (1:1);Polyinosinate-polycytidylate complex;NSC 120949;NSC 123233;NSC 128576;Polyinosine-polycytidylic acid;Poly(I)-poly(C);Poly I:C;104888-55-3;53539-97-2;61216-07-7
24939-03-5 - / 50% Inquiry

Prostaglandin E1

Prost-13-en-1-oic acid,11,15-dihydroxy-9-oxo-,(11α,13E,15S)-;Cyclopentaneheptanoic acid,3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-,(-)-;Cyclopentaneheptanoic acid,3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-;(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid;PGE1;Prostaglandin E1;11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid;(-)-Prostaglandin E1;l-Prostaglandin E1;11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid;Alprostadil;U 10136;Prostandin;l-PGE1;Prostandin 500;Caverject;Alprox TD;Palux;ONO 1608;Lipoprost;Topiglan;SEPA-PGE1;SEPA-alprostadil;SEPA-prostaglandin E1;Minprog;Prostivas;Prostin VR Pediatric;Liple;NSC 165559;Caveject;Vasaprostan;Liprostin;Eglandin;Lipo PGE1;Alprostan;50-83-9;22299-37-2;50865-30-0
745-65-3 - / 98% Inquiry

Prostaglandin E2

Prosta-5,13-dien-1-oic acid,11,15-dihydroxy-9-oxo-,(5Z,11α,13E,15S)-;5-Heptenoic acid,7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;5-Heptenoic acid,7-[3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;PGE2;Prostaglandin E2;U 12062;11α,15α-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid;(15S)-Prostaglandin E2;(-)-Prostaglandin E2;11α,15α-Dihydroxy-9-ketoprosta-5,13-dienoic acid;Dinoprostone;Prostin E2;Prepidil;l-Prostaglandin E2;l-PGE2;Minprostin E2;Prostenon;Prostenone;Cervidil;Prostin;Prostin (prostaglandin);Glandin;Prostarmon E;Cerviprost;Propess;Minprositin E2;Enzaprost E;NSC 165560;NSC 196514;Primiprost;Cerviprime;11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11α,13E,15S);5: PN: US20150065431 SEQID: 5 claimed sequence;7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentyl]-5-heptenoic acid
363-24-6 - / 98% Inquiry

Trypsin inhibitor,pancreatic basic

Trypsin inhibitor,pancreatic basic;Pancreatic basic trypsin inhibitor;Basic pancreatic trypsin inhibitor;Pancreatic trypsin inhibitor;Pancreatic trypsin inhibitor (Kunitz);Kunitz pancreatic trypsin inhibitor;Antilysin;Antilysine;Aprotinin;Trasylol;Trypsin-kallikrein inhibitor (Kunitz);Kallikrein-trypsin inactivator;Trypsin inhibitor,Trasylol;Kunitz trypsin inhibitor;Zymofren;Triazinin;Bovine pancreatic trypsin inhibitor;BPTI;Kunitz-type inhibitor;Kunitz-type proteinase inhibitor;Kunitz-type trypsin inhibitor;Bovine basic pancreatic trypsin inhibitor;BPTI trypsin inhibitor;Kunitz protease inhibitor;Bovine trypsin inhibitor;Trasuylol;Onquinin;Antikrein;RP 9921;Fosten;Bayer A 128;Kiker 52G;Trazinin;Kir Richter;Repulson;Protease inhibitor,Kunitz type;Aprostat;Antiprovir;9004-04-0;9039-77-4;11005-72-4;11132-77-7;39283-52-8;69431-34-1
9087-70-1 - / 98% Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

China

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.